These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females. Behrman-Lay AM; Paul RH; Heaps-Woodruff J; Baker LM; Usher C; Ances BM J Neurovirol; 2016 Feb; 22(1):93-103. PubMed ID: 26306688 [TBL] [Abstract][Full Text] [Related]
3. Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60. Guha A; Wang L; Tanenbaum A; Esmaeili-Firidouni P; Wendelken LA; Busovaca E; Clifford K; Desai A; Ances BM; Valcour V J Neurovirol; 2016 Feb; 22(1):80-7. PubMed ID: 26265137 [TBL] [Abstract][Full Text] [Related]
4. Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients. Casado JL; Marín A; Moreno A; Iglesias V; Perez-Elías MJ; Moreno S; Corral I J Neurovirol; 2014 Feb; 20(1):54-61. PubMed ID: 24420449 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. Fabbiani M; Ciccarelli N; Tana M; Farina S; Baldonero E; Di Cristo V; Colafigli M; Tamburrini E; Cauda R; Silveri MC; Grima P; Di Giambenedetto S HIV Med; 2013 Mar; 14(3):136-44. PubMed ID: 22994586 [TBL] [Abstract][Full Text] [Related]
6. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK; AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility. Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553 [TBL] [Abstract][Full Text] [Related]
9. HIV-associated cognitive impairment before and after the advent of combination therapy. Sacktor N; McDermott MP; Marder K; Schifitto G; Selnes OA; McArthur JC; Stern Y; Albert S; Palumbo D; Kieburtz K; De Marcaida JA; Cohen B; Epstein L J Neurovirol; 2002 Apr; 8(2):136-42. PubMed ID: 11935465 [TBL] [Abstract][Full Text] [Related]
10. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. Cysique LA; Letendre SL; Ake C; Jin H; Franklin DR; Gupta S; Shi C; Yu X; Wu Z; Abramson IS; Grant I; Heaton RK; AIDS; 2010 Apr; 24(7):983-90. PubMed ID: 20299964 [TBL] [Abstract][Full Text] [Related]
11. The aging of human-immunodeficiency-virus-associated neurocognitive disorders. Ikezu T J Neuroimmune Pharmacol; 2009 Jun; 4(2):161-2. PubMed ID: 19415503 [No Abstract] [Full Text] [Related]
12. Neurocognitive impairment in early HIV-positive individuals. Mandal N; Singh OP; Bhattacharya S; Chatterji S; Biswas A; Sen S J Indian Med Assoc; 2008 Jul; 106(7):442, 447-9, 453. PubMed ID: 18975499 [TBL] [Abstract][Full Text] [Related]
13. Assessment of cognitive function in asymptomatic HIV-positive subjects. Grassi MP; Perin C; Borella M; Mangoni A Eur Neurol; 1999; 42(4):225-9. PubMed ID: 10567820 [TBL] [Abstract][Full Text] [Related]
14. Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors. Musindo O; Bangirana P; Kigamwa P; Okoth R; Kumar M AIDS Care; 2018 May; 30(5):618-622. PubMed ID: 29353495 [TBL] [Abstract][Full Text] [Related]
15. HIV-associated neurocognitive disorders and central nervous system drug penetration: what next? Marra CM Antivir Ther; 2015; 20(4):365-7. PubMed ID: 25781980 [TBL] [Abstract][Full Text] [Related]
16. Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients. Ciccarelli N; Grima P; Fabbiani M; Baldonero E; Borghetti A; Milanini B; Limiti S; Colafigli M; Tamburrini E; Cauda R; De Luca A; Di Giambenedetto S Antivir Ther; 2015; 20(4):433-40. PubMed ID: 25504667 [TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. Suarez S; Baril L; Stankoff B; Khellaf M; Dubois B; Lubetzki C; Bricaire F; Hauw JJ AIDS; 2001 Jan; 15(2):195-200. PubMed ID: 11216927 [TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness in HIV-infected individuals: relationship of premature atherosclerosis to neuropsychological deficits? Yaldizli O; Kastrup O; Obermann M; Esser S; Wilhelm H; Ley C; Diener HC; Maschke M Eur Neurol; 2006; 55(3):166-71. PubMed ID: 16733357 [TBL] [Abstract][Full Text] [Related]
19. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. Tozzi V; Balestra P; Galgani S; Narciso P; Ferri F; Sebastiani G; D'Amato C; Affricano C; Pigorini F; Pau FM; De Felici A; Benedetto A AIDS; 1999 Oct; 13(14):1889-97. PubMed ID: 10513647 [TBL] [Abstract][Full Text] [Related]
20. HIV-associated neurocognitive disorders: still a hot topic? Levy I Isr Med Assoc J; 2015 Jan; 17(1):52-3. PubMed ID: 25739179 [No Abstract] [Full Text] [Related] [Next] [New Search]